Sandoz to build biologics plant in Slovenia
European Pharmaceutical Review
MARCH 13, 2023
“Not only does the location has offer competitive costs [but it has] proximity to our existing European-based production and commercial operations.” Full operations is provisionally planned for late 2026. This brings the total new investment commitment to the network in the past few years to €250 million.
Let's personalize your content